1. Home
  2. NMRA vs LEGT Comparison

NMRA vs LEGT Comparison

Compare NMRA & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • LEGT
  • Stock Information
  • Founded
  • NMRA 2019
  • LEGT 2023
  • Country
  • NMRA United States
  • LEGT United States
  • Employees
  • NMRA N/A
  • LEGT N/A
  • Industry
  • NMRA
  • LEGT
  • Sector
  • NMRA
  • LEGT
  • Exchange
  • NMRA Nasdaq
  • LEGT Nasdaq
  • Market Cap
  • NMRA 268.5M
  • LEGT 277.1M
  • IPO Year
  • NMRA 2023
  • LEGT 2024
  • Fundamental
  • Price
  • NMRA $1.73
  • LEGT $10.88
  • Analyst Decision
  • NMRA Hold
  • LEGT
  • Analyst Count
  • NMRA 8
  • LEGT 0
  • Target Price
  • NMRA $5.83
  • LEGT N/A
  • AVG Volume (30 Days)
  • NMRA 498.0K
  • LEGT 3.8K
  • Earning Date
  • NMRA 11-11-2025
  • LEGT 01-01-0001
  • Dividend Yield
  • NMRA N/A
  • LEGT N/A
  • EPS Growth
  • NMRA N/A
  • LEGT N/A
  • EPS
  • NMRA N/A
  • LEGT 0.33
  • Revenue
  • NMRA N/A
  • LEGT N/A
  • Revenue This Year
  • NMRA N/A
  • LEGT N/A
  • Revenue Next Year
  • NMRA N/A
  • LEGT N/A
  • P/E Ratio
  • NMRA N/A
  • LEGT $33.15
  • Revenue Growth
  • NMRA N/A
  • LEGT N/A
  • 52 Week Low
  • NMRA $0.61
  • LEGT $10.20
  • 52 Week High
  • NMRA $17.19
  • LEGT $10.95
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 47.30
  • LEGT 66.26
  • Support Level
  • NMRA $1.74
  • LEGT $10.79
  • Resistance Level
  • NMRA $1.90
  • LEGT $10.95
  • Average True Range (ATR)
  • NMRA 0.12
  • LEGT 0.03
  • MACD
  • NMRA -0.02
  • LEGT 0.01
  • Stochastic Oscillator
  • NMRA 10.94
  • LEGT 66.67

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About LEGT Legato Merger Corp. III

Legato Merger Corp III is a blank check company.

Share on Social Networks: